WARSAW — Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced it will participate in the Goldman Sachs 2015 European Medtech and Healthcare Conference at the Goldman Sachs offices, London, Thursday, Sept. 10.

About The Company

Founded in 1927 and headquartered in Warsaw, Zimmer Biomet is a global leader in musculoskeletal healthcare that designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

Zimmer Biomet collaborates with healthcare professionals around the globe to advance the pace of innovation. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues.

Zimmer Biomet has operations in more than 25 countries around the world and sells products in more than 100 countries. For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter atwww.twitter.com/zimmerbiomet.